
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-07-19 10:10:15Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news article
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 9.99% Gain — Buyers Queue, Sellers Absent
2026-07-09 12:00:06At Rs 59.43, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 9.99% on 9 Jul 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Krebs Biochemicals & Industries Ltd Locks at Lower Circuit With 6.51% Loss — Sellers Queue, No Buyers in Sight
2026-07-08 12:00:07At Rs 54.39, sellers were still queuing — but there were no buyers willing to take the other side. Krebs Biochemicals & Industries Ltd locked at its lower circuit of 6.51% on 7 Jul 2026, with unfilled sell orders and a frozen price, reflecting a pronounced imbalance in supply and demand.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-07-07 10:10:21Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-06-26 10:10:18Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 26 June 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-06-15 10:10:37Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-06-01 10:10:19Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 01 June 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 4.78% Gain — Buyers Queue, Sellers Absent
2026-05-27 10:00:09At Rs 68.14, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 4.78% on 27 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-05-26 10:00:11At Rs 64.9, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 5% on 26 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news articleKrebs Biochemicals and Industries Limited - Resignation
04-Nov-2019 | Source : NSEKrebs Biochemicals and Industries Limited has informed the Exchange regarding Resignation of Mr Phani Srinath as Chief Financial Officer of the company w.e.f. November 02, 2019.
Krebs Biochemicals and Industries Limited - Statement of deviation(s) or variation(s) under Reg. 32
31-Oct-2019 | Source : NSEKrebs Biochemicals and Industries Limited Limited has informed the Exchange regarding Statement of deviation(s) or variation(s) under Reg. 32 of SEBI (LODR) Regulations 2015
Krebs Biochemicals and Industries Limited - Shareholders meeting
29-Oct-2019 | Source : NSEKrebs Biochemicals and Industries Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on November 22, 2019
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19






